Agomelatine: is it really a firstline drug?
Vol 3 #2 March 2018 Agomelatine is listed as a firstline medication for the treament of depression in a number of guidelines including Canadian Guidelines. This is the case eventhough Agomelatine is not approved for use in Canada..
- Posted by Editor JPR
- Posted in Abstracts,Brief Review
Should Canadian patients look forward to aducanumab for Alzheimer disease?
Journal of Psychiatry Reform Vol 10 #12 This is an Open Access article from CMAJ distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence. Open Access Should Canadian patients look forward to aduca..
- Posted by Alan Eppel
- Posted in Creative Commons Republished,Editorials & Commentary